ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a subtype of breast cancer that based on immunohistochemistry features of estrogen receptor (ER) negative, progesterone receptor (PR) negative and human epidermal growth factor receptor 2 (HER2) negative (Perou, 2011).